BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2002
View Archived Issues
Use of Apligraf in the treatment of full thickness wounds
Read More
Hyaluronic acid-based therapeutic for hereditary pulmonary disorder safe in early clinical trial
Read More
Radiopharmaceutical from TransMolecular cleared for testing in humans
Read More
Preclinical data provide rationale for phase III evaluation of exisulind/docetaxel in NSCLC
Read More
Involvement of tachykininergic and cholinergic pathways in the prokinetic effects of ML-10302
Read More
Losartan superior to atenolol in reducing cardiovascular events in LIFE trial
Read More
AJW-200 exerts a sustained antiplatelet effect without excessive bleeding in primates
Read More
Novel antidiabetic tetrazolylphenylacetamides described in recent patent
Read More
Compounds for autoimmune diseases under study at Mitsubishi Pharma
Read More
Heterocyclic compounds useful in obesity and diabetes according to Shionogi patent
Read More
Naturally produced telomerase inhibitor identified by Japanese scientists
Read More
Kyowa Hakko team designs new inhibitors of adenosine uptake
Read More
Antibacterial nocathiacin derivatives in development at BMS
Read More
Novel compounds patented by Brigham & Women's for use in Alzheimer's disease
Read More
Treatment initiated in at-home phase II/III trial of Alista for FSAD
Read More
Guidant licenses everolimus from Novartis for use in drug-eluting stents
Read More
AstraZeneca returns rights, preclinical data for RSD-1122
Read More
Chiron completes acquisition of Matrix
Read More
LifeTECH changes name to IATRA Life Sciences
Read More
Combinations of morphine, clonidine and cholinesterase inhibitors examined in rat formalin test
Read More
Paxil CR launch date set
Read More
Multiple breast cancer suppressive activities for pomegranate (Punica granatum) fractions
Read More
Phase I ADL-10-0101 program expanded
Read More
New Thai study of Remune in HIV to broaden use
Read More
Stannsoporfin cleared to enter phase III trial for prevention of hyperbilirubinemia
Read More
Interneuron renamed Indevus Pharmaceuticals
Read More